Trending

The Nooner, by 24/7 Market News, for June 29, 2022

(24/7 MARKET NEWS) Yesterday we stated that Decibel Therapeutics (NASDAQ: DBTX) shares were “poised to gain as they report top line data from Phase 1 trial” and that’s exactly what’s happening today, as it’s trading at $3.79, $1.14 (+43.02%) higher, on nearly 3 million shares.

Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares are at $0.326, up $0.207 (+173.95%), on over 445 million shares traded. Allena hit a high of $0.44, after it cancelled its recent dilutive Common Shares Sales Agreement, and, provided that it can hold the $0.32, it may make another run at the high of the day.

Interesting Charts

Catalyst Biosciences Inc. (NASDAQ: CBIO) shares are up $0.215 (+14.24%), at $1.725, on nearly 23 million shares traded, on news that the company will distribute its cash to shareholders. Catalyst Biosciences has been trending up for more than a month and, if it can break through the $2 level resistance, it would have a gap between that and $3.               

Trevi Therapeutics, Inc. (NASDAQ: TRVI) announced Positive Results this morning and hit a high of $2.78. It’s now at $2.28, up $0.26 (+12.87%), on more than 48 million shares, and it has a compelling chart.

Squeezes

Bluebird bio Inc. (NASDAQ: BLUE) is trending up, again, at $4.5096, up $0.4696 (+11.62%), on over 6 million shares. Bluebird may become a short squeeze play.

Volume is the story with Endo International PLCs (NASDAQ: ENDP), so, although it’s down $0.1339 (-18.86%), at $0.5761. the more than 134 million shares traded is worthy of keeping an eye on this one.

24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.

Please go to www.247marketnews.com or https://www.247marketnews.com/terms-disclaimer/ for further information.

RelatedNews

Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist